|
Michael Schlosser serves as the President of MBR. As president, his responsibilities include providing strategic direction, forming alliances with complementary CROs and experts, and ensuring the highest standards of scientific integrity.Mike has 19 years of experience within the pharmaceutical industry and 25 years of experience in toxicology. Prior to founding MBR, he was Senior Director of Safety Sciences at Pfizer/Pharmacia (formerly Searle/Monsanto). Prior to that, he served as the Director of Experimental Toxicology and Pathology at Astra Pharmaceuticals. Mike was also the Head of Experimental Toxicology at Ciba-Geigy Pharmaceuticals.Mike holds a Ph.D. in toxicology and pharmacology from the University of Mississippi. He was certified as Diplomate of the American Board of Toxicology (DABT) in 1990. | 